查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386580

间质性血管细胞群体市场报告：2030 年趋势、预测与竞争分析

Stromal Vascular Fraction Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

间质血管细胞群的趋势与预测

2030年，全球基质血管细胞群市场预计将达到1.23亿美元，2024年至2030年的年复合成长率为5.1%。该市场的主要驱动因素包括骨骼和肌肉疾病盛行率的增加、对干细胞治疗的认识和知识的增加、再生医学的发展以及大量的临床前和临床研究工作。全球基质血管细胞群市场的未来充满希望，医院、专科诊所和干细胞库/实验室市场充满机会。

间质血管细胞群市场洞察

Lucintel 预测，在预测期内，软组织应用仍将是最大的细分市场。

由于私人医疗机构的持续扩张，包括农村地区私立医院数量的增加，亚太地区在预测期内将继续成为最大的地区。基质血管部分将受益于持续的研究和开发倡议，刺激最尖端科技的发展和不断增长的需求。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪个产业将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球基质血管细胞群市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球基质血管细胞群市场趋势（2018-2023）与预测（2024-2030）
  • 全球基质血管细胞群市场（按产品）
    • SVF 抽吸产品
    • SVF传输产品
    • SVF绝缘产品
  • 全球基质血管细胞群市场（依应用）
    • 化妆品应用
    • 整形外科应用
    • 应用于软组织
    • 其他的
  • 以最终用途分類的全球基质血管细胞组​​市场
    • 医院
    • 专科诊所
    • 干细胞库/实验室
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球基质血管细胞群市场
  • 北美基质血管细胞群市场
  • 欧洲基质血管细胞群市场
  • 亚太基质血管细胞群市场
  • 其他区域基质血管细胞市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球基质血管细胞组​​市场成长机会（按产品）
    • 全球基质血管细胞群市场成长机会（依应用）
    • 全球基质血管细胞组​​市场成长机会（依最终用途）
    • 全球基质血管细胞组​​市场成长机会（按地区）
  • 全球基质血管细胞群市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球基质血管细胞群市场的容量
    • 全球基质血管细胞群市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Cytori Therapeutics
  • IntelliCell BioSciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • InGeneron
  • Human med
  • Hairline International
  • Genesis Biosystems
  • Kyocera
简介目录

Stromal Vascular Fraction Trends and Forecast

The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets. The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

A more than 150-page report is developed to help in your business decisions.

Stromal Vascular Fraction by Segment

The study includes a forecast for the global stromal vascular fraction by product, application, end use, and region.

Stromal Vascular Fraction Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products

Stromal Vascular Fraction Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

Stromal Vascular Fraction Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Stromal Vascular Fraction Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stromal Vascular Fraction Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stromal vascular fraction companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stromal vascular fraction companies profiled in this report include-

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Stromal Vascular Fraction Market Insights

Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Features of the Global Stromal Vascular Fraction Market

Market Size Estimates: Stromal vascular fraction market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stromal vascular fraction market size by product, application, end use, and region in terms of value ($M).

Regional Analysis: Stromal vascular fraction market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the stromal vascular fraction market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stromal vascular fraction market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stromal vascular fraction market size?

Answer: The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030.

Q.2 What is the growth forecast for stromal vascular fraction market?

Answer: The global stromal vascular fraction market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stromal vascular fraction market?

Answer: The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

Q4. What are the major segments for stromal vascular fraction market?

Answer: The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets.

Q5. Who are the key stromal vascular fraction market companies?

Answer: Some of the key stromal vascular fraction companies are as follows:

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Q6. Which stromal vascular fraction market segment will be the largest in future?

Answer: Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

Q7. In stromal vascular fraction market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stromal vascular fraction market by product (SVF aspiration products, SVF transfer products, and SVF isolation products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), end use (hospitals, specialty clinics, stem cell banks/laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stromal Vascular Fraction Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stromal Vascular Fraction Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stromal Vascular Fraction Market by Product
    • 3.3.1: SVF Aspiration Products
    • 3.3.2: SVF Transfer Products
    • 3.3.3: SVF Isolation Products
  • 3.4: Global Stromal Vascular Fraction Market by Application
    • 3.4.1: Cosmetic Applications
    • 3.4.2: Orthopedic Applications
    • 3.4.3: Soft Tissue Applications
    • 3.4.4: Others
  • 3.5: Global Stromal Vascular Fraction Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Stem Cell Banks/Laboratories
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stromal Vascular Fraction Market by Region
  • 4.2: North American Stromal Vascular Fraction Market
    • 4.2.1: North American Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.2.2: North American Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.3: European Stromal Vascular Fraction Market
    • 4.3.1: European Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.3.2: European Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.4: APAC Stromal Vascular Fraction Market
    • 4.4.1: APAC Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.4.2: APAC Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.5: ROW Stromal Vascular Fraction Market
    • 4.5.1: ROW Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.5.2: ROW Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stromal Vascular Fraction Market by Product
    • 6.1.2: Growth Opportunities for the Global Stromal Vascular Fraction Market by Application
    • 6.1.3: Growth Opportunities for the Global Stromal Vascular Fraction Market by End Use
    • 6.1.4: Growth Opportunities for the Global Stromal Vascular Fraction Market by Region
  • 6.2: Emerging Trends in the Global Stromal Vascular Fraction Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stromal Vascular Fraction Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stromal Vascular Fraction Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cytori Therapeutics
  • 7.2: IntelliCell BioSciences
  • 7.3: Cellular Biomedicines Group
  • 7.4: Lifecell
  • 7.5: Tissue Genesis
  • 7.6: InGeneron
  • 7.7: Human med
  • 7.8: Hairline International
  • 7.9: Genesis Biosystems
  • 7.10: Kyocera